Search research articles
Contact Us
Filters
Showing results (41-50 of 59) with videos related to
Page
of 6
Sort By:
Cancer
|
June 25, 2025
Consensus guideline for the management of gastric cancer with synchronous peritoneal metastases
Samuel D Butensky, Varun V Bansal, David G Su, et al.
The Oncologist
|
March 20, 2023
Atezolizumab Plus PEGPH20 Versus Chemotherapy in Advanced Pancreatic Ductal Adenocarcinoma and Gastric Cancer: MORPHEUS Phase Ib/II Umbrella Randomized Study Platform
Andrew H Ko, Kyu-Pyo Kim, Jens T Siveke, et al.
British Journal of Cancer
|
December 22, 2023
NCI10066: a Phase 1/2 study of olaparib in combination with ramucirumab in previously treated metastatic gastric and gastroesophageal junction adenocarcinoma
Michael Cecchini, James M Cleary, Yu Shyr, et al.
Annals of Surgical Oncology
|
June 25, 2025
Consensus Guideline for the Management of Gastric Cancer with Synchronous Peritoneal Metastases
Samuel D Butensky, Varun V Bansal, David G Su, et al.
The Lancet. Gastroenterology & Hepatology
|
January 19, 2020
Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 study
Philip A Philip, Jill Lacy, Fabienne Portales, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 2024
Devimistat (CPI-613) With Modified Fluorouarcil, Oxaliplatin, Irinotecan, and Leucovorin (FFX) Versus FFX for Patients With Metastatic Adenocarcinoma of the Pancreas: The Phase III AVENGER 500 Study
Philip A Philip, Vaibhav Sahai, Nathan Bahary, et al.
The Lancet. Oncology
|
May 11, 2016
FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis
Mustafa Suker, Berend R Beumer, Eran Sadot, et al.
The Lancet. Oncology
|
February 6, 2019
Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial
Charles S Fuchs, Kohei Shitara, Maria Di Bartolomeo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 25, 2020
Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma
Eric Van Cutsem, Margaret A Tempero, Darren Sigal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 5, 2023
Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline
Manish A Shah, Erin B Kennedy, Ashley E Alarcon-Rozas, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 59) with videos related to
Sort By:
Page
of 6
Cancer
|
June 25, 2025
Consensus guideline for the management of gastric cancer with synchronous peritoneal metastases
Samuel D Butensky, Varun V Bansal, David G Su, et al.
The Oncologist
|
March 20, 2023
Atezolizumab Plus PEGPH20 Versus Chemotherapy in Advanced Pancreatic Ductal Adenocarcinoma and Gastric Cancer: MORPHEUS Phase Ib/II Umbrella Randomized Study Platform
Andrew H Ko, Kyu-Pyo Kim, Jens T Siveke, et al.
British Journal of Cancer
|
December 22, 2023
NCI10066: a Phase 1/2 study of olaparib in combination with ramucirumab in previously treated metastatic gastric and gastroesophageal junction adenocarcinoma
Michael Cecchini, James M Cleary, Yu Shyr, et al.
Annals of Surgical Oncology
|
June 25, 2025
Consensus Guideline for the Management of Gastric Cancer with Synchronous Peritoneal Metastases
Samuel D Butensky, Varun V Bansal, David G Su, et al.
The Lancet. Gastroenterology & Hepatology
|
January 19, 2020
Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 study
Philip A Philip, Jill Lacy, Fabienne Portales, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 2024
Devimistat (CPI-613) With Modified Fluorouarcil, Oxaliplatin, Irinotecan, and Leucovorin (FFX) Versus FFX for Patients With Metastatic Adenocarcinoma of the Pancreas: The Phase III AVENGER 500 Study
Philip A Philip, Vaibhav Sahai, Nathan Bahary, et al.
The Lancet. Oncology
|
May 11, 2016
FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis
Mustafa Suker, Berend R Beumer, Eran Sadot, et al.
The Lancet. Oncology
|
February 6, 2019
Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial
Charles S Fuchs, Kohei Shitara, Maria Di Bartolomeo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 25, 2020
Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma
Eric Van Cutsem, Margaret A Tempero, Darren Sigal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 5, 2023
Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline
Manish A Shah, Erin B Kennedy, Ashley E Alarcon-Rozas, et al.
Page
of 6